MODAG
LIVE

Serial Number

79292215

Owner

MODAG GmbH

Attorney

Catherine F. Hoffman

Filing Date

Jan 31, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MODAG Trademark

Serial Number: 79292215 • Registration: 6422358

MODAG is a trademark filed by MODAG GmbH on January 31, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

MODAG GmbH (3 trademarks)

Mikroforum Ring 3
Wendelsheim 55234 , DE

Entity Type: 99

Trademark Details

Filing Date

January 31, 2020

Registration Date

July 20, 2021

Published for Opposition

May 4, 2021

Goods & Services

Pharmaceutical drugs and medicines for the treatment of the nervous system and for the treatment of diseases characterized by pathological protein aggregation; diagnostic preparations for medical purposes

Chemical substances, chemical materials, chemical compositions and chemical preparations, all of the foregoing for use in science

Medical services in the field of diseases characterized by pathological protein aggregation; Medical diagnosis of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; medical services in the field of neurodegenerative diseases; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis, prognosis and treatment of neurodegenerative diseases and diseases characterized by pathological protein aggregation; providing medical data and information in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation to healthcare professionals; rental of medical apparatus and equipment, and fittings therefor

Medical apparatus and instruments for monitoring molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor; Medical diagnostic apparatus for testing molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor

Scientific and technological services, namely, research and design in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; industrial analysis and research services in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; biological research; research and development of new products for others; Conducting clinical trials for others in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; Scientific laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; pharmaceutical drug development services

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Oct 11, 2024 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 26, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 26, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 26, 2024 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 19, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2021 FICS
FINAL DISPOSITION PROCESSED
Dec 1, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 20, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 4, 2021 PUBO
NOTIFICATION PROCESSED BY IB
May 2, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 14, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2021 TROA
REFUSAL PROCESSED BY IB
Oct 19, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Aug 25, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 22, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 21, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 20, 2020 REPR